-
Study aim
-
Considering the high prevalence of diabetic wounds and the inability of current dressings to meet the needs of patients and the expectations of doctors, the existence of an effective dressing that has a long-term durability and the ability to prevent re-infection of the wound is required
-
Design
-
The study is a pilot study and will be conducted on 20 volunteers with type 2 diabetes who have diabetic foot ulcers. The non-random sampling method is easy and people will be included in the study in order.
-
Settings and conduct
-
In order to conduct this pilot study, 20 human subjects with type 2 diabetes who have diabetic foot ulcers entered the study with written consent and completely voluntarily, and gelatin hydrogel dressing was applied to the wound which was completely clean and free of infection and in the stage of good granulation tissue. is located, is used.
-
Participants/Inclusion and exclusion criteria
-
Entry criteria: over 18 years old - suffering from a diabetic foot ulcer that is in good granulation tissue condition
Exclusion criteria: having severe clinical conditions such as active cancer, chronic hepatitis, HIV, uncontrolled autoimmune diseases, platelet problems, thrombocytopenia, bone marrow aplasia, blood infection, osteomyelitis, mental problems, local or systemic treatments such as chemotherapy
-
Intervention groups
-
There is only one treatment group for which the intervention is processed in a way that the hydrogel is applied on the wound bed, and the final results will be evaluated on the base of research variables (including the recovery time, duration of hydrogel retention on the wound, protection of the wound surface, and protection of the moist surface) at intervals of 3 and 7 days
-
Main outcome variables
-
Absorption of secretions-Persistence on the wound-Protect the wound surface-Wet surface protection-Duration of relative recovery